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Crustacean hyperglycemic hormone (CHH) was isolated from sinus glands of Carcinus maenas, and its primary structure 
was determined by manual microsequencing, using the DABITC-PITC double-coupling method. The neurohormone con- 
sists of 72 amino acid residues (8524 Da). Three disulfide bridges are present and both the N- and C-terminus are blocked. 
CHH does not show significant sequence homology to any known peptide hormone or protein. 
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1. INTRODUCTION 
The existence of a 'diabetogenic factor' in the 
crustacean eyestalk was demonstrated more than 
40 years ago [1]. Subsequent studies on the 
physiology and biochemistry of this 'crustacean 
hyperglycemic hormone (CHH)', as it became 
known, have been summarized in recent reviews 
[2,3]. In addition to its well-documented role as a 
blood glucose-regulating hormone, CHH has been 
found to .be a potent secretagogue, releasing 
digestive nzymes from the hepatopancreas [3]. 
Thus, it may be a metabolic hormone with multiple 
functions. 
Antisera to CHH, employed in im- 
munocytochemical studies, have revealed a 
distinct, classical neurosecretory pathway in the 
eyestalk, consisting of perikarya in the so called X- 
organ in the medulla terminalis and axon endings 
in the neurohemal sinus gland (SG) [2,4]. By 
radioimmunoassay [5], resting hemolymph levels 
and elevated levels under physiological stress could 
be measured [6], confirming a hormonal role of 
CHH in vivo. 
Due to the abundance of CHH-axon terminals, 
the SG is an excellent, enriched source for isolation 
of the hormone. Isolation of CHH by a simple two- 
step HPLC procedure, from Carcinus maenas and 
some other species, and amino acid composition 
data, have previously been reported from this 
laboratory [2,7,8]. 
Here we report the complete amino acid se- 
quence of CHH from the shore crab, C. maenas. 
2. MATERIALS AND METHODS 
Correspondence address: R. Keller, Institut ftir Zoophysiologie 
der Universit/it Bonn, Endenicher Allee 11-13, D-5300 Bonn l, 
FRG 
Abbreviations: DABITC, 4-N,N-dimethylaminoazobenzene 
4'-isothiocyanate; DABTH, 4-N,N-dimethylaminoazobenzene 
thiohydantoin; PITC, phenylisothiocyanate; HPLC, high- 
performance liquid chromatography; TFA, trifluoroacetic a id. 
2.1. Isolation of CHH 
Dissection and extraction of sinus glands and purification of 
CHH by HPLC have been described [7,8[. HPLC yields two 
CHH peaks, a minor pre-peak (approx. 10°70 of total) and a 
slightly later eluting main peak. Both forms do not differ in 
hyperglycemic a tivity, and no significant differences in amino 
acid composition could be demonstrated. This paper describes 
the sequencing of the main peak material. 
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2.2. Derivatization of disulfide bonds 
2.2.1. Oxidation 
Performic acid oxidation was performed according to [9]. 
2.2.2. Reduction and alkylation 
Samples were dissolved in 100 mM Tris-HC1 (pH 8.3) con- 
taining 6 M guanidine HC1 and 2 mM EDTA, and incubated for 
1 h at 37°C. Reduction with dithiothreitol (DTT) and alkylation 
with iodoacctic acid were performed as in [10]. Acetic acid 
(HOAc) was added to a final concentration of 50070. S-CM- 
CHH was separated on a Sephadex G-25 column (0.6x 13 cm), 
with 50070 HOAc as eluant, and lyophilized. 
Pyridylcthylation: Reduction and reaction with 4-vinyl- 
pyridine were performed according to [11], but with 100 mM 
Tris-HCI (pH 8.3) as buffer. S-Pyridylethyl-CHH (S-PE-CHH) 
was isolated by HPLC as described insection 2.4 (conditions b). 
2.3. Enzymatic digestion 
2.3.1. Trypsin (TPCK-treated, Worthington) 
Oxidized and S-CM-CHH: Samples were incubated in 1070 
NI-I4HCO3 buffer (pH 8.8) for 4 h at 37°C at an en- 
zyme/substrate ratio of 1:30 (w/w). Native CHH and en- 
doprotease Asp-N-generated fragments of native CHH: Incuba- 
tions were carried out in 100 mM Tris-HCl (pH 8.3) containing 
5070 acetonitrile (CH3CN) for 15 h at 37°C; the en- 
zyme/substrate ratio was 1:20. 
2.3.2. Endoprotease GIu-C (Boehringer sequencing grade) 
Digestion was carried out in 100 mM NI-I4HCO3 buffer (pH 
7.8), containing 2 mM EDTA, for 8 h at 37°C; en- 
zyme/substrate ratio, 1:30. 
2.3.3. Endoprotease Asp-N (Boehringer sequencing grade) 
Native, oxidized and S-PE-CHH was digested in 50 mM Tris- 
HCI (pH 8.0) for 18 h at 37°C. In the case of S-PE-CHH, 10070 
CH3CN was added as the material was poorly soluble at pH 8.0; 
enzyme/suhstrate ratio, 1:100. 
2.3.4. Carboxypeptidase P (Boehringer sequencing grade) 
About 8 nmol C-terminal tryptic fragment (T2) were treated 
with 400 ng enzyme in 50/tl of 50 mM sodium phosphate buffer 
(pH 6.5) for 15 h at 25°C. 
2.3.5. Pyroglutamate-aminopeptidase (Boehringer) 
The N-terminal tetrapeptide (G2) was cleaved in 100 mM Tris- 
HCI (pH 7.5), containing 4 mM DTT and 4 mM EDTA, for 60 
min at 30°C. Of the enzyme, 2/3 were added initially and 1/3 
after 15 min (final enzyme/substrate r tio, 40:1, w/w). Reaction 
was stopped by dilution with 4 N HOAc. 
2.4. Separation of fragr~ents 
This was achieved by HPLC on a/zBondapak phenyl column 
(0.39 x 30 cm, Millipore-Waters) with linear gradient elution at 
a flow rate of 0.9 ml/min and monitoring at 210 mm. Solvent 
A, 0.11 070 TFA; solvent B, 0.1007o TFA/60% CH3CN. Two pro- 
tocols were used: (a) 10-80070 B in 90 min, (b) 10-80070 B in 60 
min. 
2.5. Amino acid analysis 
A Biotronic LC 5000 analyzer with ninhydrin postcolumn 
reaction was used to determine amino acid compositions and 
quantities of peptides after hydrolysis with constant-boiling 
HC1 in vacuo for 1 h at 150°C [11]. 
2.6. Microsequencing 
Sequencing was carried out manually by the DABITC-PITC 
double-coupling method [12]. DABTH amino acids were 
separated and identified by HPLC on a Nucleosil C18 column 
(3.9x 30 cm, particle size 5/~m, Macherey and Nagel). Solvent 
A, 35 mM sodium acetate buffer (pH 5.0); solvent B, CH3CN. 
A linear gradient from 30 to 70°70 B in 60 min at a flow rate of 
0.5 ml/min was used, with monitoring at 430 nm. 
2.7. FAB-mass pectrometry 
FAB-MS was performed on a ZAB HF instrument (VG 
Analytical, UK). The peptide (1 #g) in aqueous solution was ap- 
plied to the target which was coated with thioglycerol as matrix. 
The target was bombarded with xenon atoms at a kinetic energy 
equivalent to 8.5-9.5 kV. A single-scan spectrum was run in the 
positive ion mode. 
3. RESULTS 
A complete set of tryptic fragments of CHH was 
obtained by HPLC (fig. 1). Manual sequencing of 
these fragments (except for the blocked N-terminal 
T4) and of overlapping fragments from en- 
doprotease Glu-C and Asp-N digestions yielded the 
sequence from position 5-71. The retention times 
of the overlapping fragments are given in table 1. 
The amino acid composition of all fragments was 
determined before sequencing. The sequencing 
strategy is shown in fig.2. There was no clear in- 
dication of microheterogeneity at any step during 
the sequencing. 
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Fig. 1. HPLC separation of fragments after trypsin digestion of 
200 ~g (23 nmol) S-CM-CHH. For details ee section 2. 
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Table 1 
HPLC retention times of endoprotease Asp-N and GIu-C 
digestion-derived fragments a 
AI.  30% B 
A5. 59% B 
A9ox 33% B 
A19ox 48o70 B 
A9 v 55% B 
G1 25% B 
G2 29°/0 B 
G5 38o70 B 
G6 440"/0 B 
conditions b
conditions a 
a For abbreviations see legend to fig.2 
The blocked, carboxymethylated N-terminal oc- 
tapeptide (T4) was analyzed by FAB-MS. No se- 
quence data were obtained, but the molecular ion 
showed amass deficit of 18, suggesting pGlu as the 
first residue. This was supported by the finding 
that T4 could be cleaved by Glu-C-protease toyield 
the N-terminal tetrapeptide G2, which proved sus- 
ceptible to pyroglutamate-aminopeptidase diges-
tion. 
C-terminal analysis: After incubation of T2 
(positions 68-72) with carboxypeptidase P, only 
Met, known to be in position 71 from the sequenc- 
ing of A9ox (fig.2), was found by amino acid 
analysis. HPLC of the enzyme digest under condi- 
tions b yielded uncleaved T2 and a tetrapeptide 
with only one Val. In the void volume, free Met 
could be detected by amino acid analysis. 
Hydrolysis of the void material gave, in addition to 
Met, the residues Lys, Val and Glx which indicated 
the existence of the uncleaved N-terminal tripep- 
tide of T2. However, Val appeared in much higher 
than equimolar quantities. This could only be 
ascribed to deamidation, by acid hydrolysis, of 
VaI-NH2 which was unexpectedly cleaved from T2 
by carboxypeptidase P. 
Assignment of disulfide bridges: Trypsin 
cleavage of native CHH yielded a fragment eluting 
at 58°70 B on HPLC (conditions b). Its amino acid 
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Fig.2. Amino acid sequence ofCHH from Carcinus maenas and positions of disulfide bonds. T, tryptic fragments; G, fragments from 
endoprotease Glu-C digestions of S-CM-CHH; A, fragments from endoprotease Asp-N digestions of native (n), pyridylethylated (p)
and oxidized (ox) CHH. Note additional cleavage sites N-terminally of cysteic acid residues. Dashed lines: residues not sequenced but 
consistent with amino acid composition. Numbering of fragments according to their positions in HPLC chromatograms. Cys residues 
underlined. 
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composition was only consistent with a linkage of 
T4 and T5, i.e. by a bridge between positions 7 and 
43. In an endoprotease Asp-N-digest of native 
CHH, a fragment eluting at 60070 B (conditions b) 
appeared whose amino acid composition cor- 
responded to positions 4-11 plus 18-53. It was fur- 
ther subjected to trypsin digestion and separated 
under the above conditions. One product, eluting 
at 42°70 B, had a composition accounting for posi- 
tions 18-23 plus 32-40, permitting assignment of 
the disulfide bridge 23-39. Another minor frag- 
ment eluting at 52070 B had a composition consis- 
tent with positions 24-31 plus 51-53, yielded the 
third disulfide bridge 26-52. Thus, the positions of 
all three disulfide bridges could be determined 
unambiguously. 
4. DISCUSSION 
The determination f the amino acid sequence of 
CHH from C. maenas howed the hormone to be 
a larger molecule than expected from earlier gel- 
filtration and amino acid composition data [2,13]. 
In accordance with the results of others on CHHs 
from different species by S DS electrophoresis [14], 
these data suggested a minimal molecular mass of 
between 6 and 7 kDa, in contrast o the value of 
8524 Da, as calculated here from the complete se- 
quence. Also, two disulfide bridges were assumed 
instead of the three that are actually present. An in- 
teresting feature of the sequence is the dibasic se- 
quence Arg-Lys (positions 67-68) near the C- 
terminus, a potential cleavage site which is ap- 
parently not used. It is currently under investiga- 
tion as to whether the truncated variant 1-65 exists 
in the SG, and whether the N-terminal peptide Val- 
Glu-Met-Val-NH2 has a specific biological activity 
of its own. 
A search of the protein and DNA-databank 
(GenBank at The Los Alamos National 
Laboratory) did not reveal any significant sequence 
homology to a known peptide hormone, neuropep- 
tide or protein. However, a scan of the databank 
with the cysteine core of CHH, allowing variable 
amino acids in between, revealed that the central 
core of four Cys residues (positions 23, 26, 39, 43) 
is identically present in the eclosion hormone of 
Manduca sexta [19]. Otherwise, there is not a single 
other identical amino acid in this region. The 
significance, if any, of this finding remains obscure 
at present. 
CHH appears to be a member of a novel peptide 
family. There is evidence of the existence of several 
important related hormones in the crustacean X- 
organ-SG system. A molecular mass in the range 
6-8 kDa seems to be a common feature. In addition 
to our observation of two peaks with CHH activity 
in Carcinus, more than one variant was also 
demonstrated in other species [14]. Peptide hor- 
mones with gonad- and vitellogenesis-inhibiting ac- 
tivity [15] and the so-called moult inhibiting hor- 
mone (MIH) may also belong to this family 
[8,16,18]. It is interesting that a value of 8.5 kDa, 
very similar to that of Carcinus CHH, has been 
reported for the MIH of the lobster [16]. We have 
isolated the MIH of Carcinus and found it to be 
similar in size and amino acid composition to CHH 
[8]. The fact that CHH has some MIH activity in- 
dicates structural similarity. A certain degree of 
immunological cross-reactivity of several lobster 
peptides is also suggestive in this respect [15,17]. 
In conclusion, there appear to be several pep- 
tides present in one species, whose structural 
similarity is reflected in a certain degree of overlap 
in biological activity. In view of the active research 
currently being performed in this field, we can ex- 
pect to see more of these peptides completely se- 
quenced in the near future. These data will provide 
a basis for understanding the evolution of the pep- 
tides, both intra- and interspecifically, and the 
emergence of different physiological functions. 
Acknowledgments: This study was supported by successive 
grants from the Deutsche Forschungsgemeinschaft (Ke 206/7). 
We thank Dr S.G. Webster, Bangor, for his generous help in 
procuring sinus glands and purified CHH, and Dr J.W. 
Slootstra, Free University Amsterdam, for performing the Gen- 
Bank search. 
REFERENCES 
[1] Abramowitz, A.A., Hisaw, F.L. and Papandrea, D.N. 
(1944) Biol. Bull. 86, 1-5. 
[2] Keller, R., Jaros, P. and Kegel, G. (1985) Am. Zool. 25, 
207 -221. 
[3] Keller, R. and Sedlmeier, D. (1988) in: Invertebrate En- 
docrinology (Laufer, H. and Downer, R.G.H. eds) vol. 2, 
pp. 315-326, A.R. Liss, New York. 
[4] Dircksen, H., Webster, S.G. and Keller, R. (1988) Cell 
Tissue Res. 251, 3-12. 
;13 
Volume 255, number 1 FEBS LETTERS September 1989 
[5] Keller, R. (1988) in: Immunological Techniques: Ar- 
thropods (Gilbert, L.I. and Miller, T.A. eds)Springer Ser. 
Exp. Entomol., pp. 253-272, Springer, Heidelberg. 
[6] Orth, H.P. (1989) PhD Dissertation, University of Bonn. 
[7] Keller, R. and Kegel, G. (1984) in: Biosynthesis, 
Metabolism and Mode of Action of Invertebrate Hor- 
mones (Hoffman, J.A. and Porchet, J.A. eds) pp. 
145-154, Springer, Heidelberg. 
[8] Webster, S.G. and Keller, R. (1986) J. Comp. Physiol. B. 
156, 617-624. 
[91 Hirs, C.H.W. (1967) Methods Enzymol. 11, 197-199. 
[10] Allen, G. (1981) Sequencing of Proteins and Peptides, 
Elsevier, Amsterdam. 
[11] Tarr, G.E. (1986) in: Methods of Protein 
Microcharacterization (Shively, J.E. ed.) pp. 155-194, 
Humana, Clifton. 
[12] Chang, J.-Y. (1981) Biochem. J. 199, 557-564. 
[13] Kleinholz, L.H. and Keller, R. (1973) Gen. Comp. Endocr. 
21,554-564. 
[14] Huberman, A. and Aguilar, M.B. (1986) Comp. Biochem. 
Physiol. 85B, 197-203. 
[15] Soyez, D. and Van Deijnen, J.E. (1987) J. Exp. Zool. 244, 
479-484. 
[16] Chang, E.S., Bruce, M.J. and Newcomb, R.W. (1987) 
Gen. Comp. Endocr. 65, 56-64. 
[17] Meusy, J.J., Martin, G., Soyez, D., Van Deijnen, J.E. and 
Gallo, J.M. (1987) Gen. Comp. Endocr. 67, 333-341. 
[18] Quackenbush, L.S. and Herrnkind, W.F. (1983) J. Crust. 
Biol. 3, 34-44. 
[19] Marti, T., Takio, K., Walsh, K.A., Terzi, G. and Truman, 
J.W. (1987) FEBS Lett. 219, 415-418. 
14 
